Rezolute (RZLT) Long-Term Debt Issuances (2012 - 2018)

Rezolute (RZLT) posted Long-Term Debt Issuances of $4.1 million for Q2 2018, up 491.43% sequentially from $700000.0 in Q1 2018.

Analysis

Rezolute (RZLT) Long-Term Debt Issuances (2012 - 2018) Analysis & Trends

Rezolute has reported Long-Term Debt Issuances for 4 years, with the latest figure at $4.1 million in Q2 2018.

Quarterly Long-Term Debt Issuances changed N/A year-over-year to $4.1 million in Q2 2018, while the trailing twelve-month figure through Jun 2019 was $4.8 million (changed 0.0% YoY) and the FY2022 annual result came in at $16.0 million, up 6.75% from the prior year.
Long-Term Debt Issuances climbed to $4.1 million in Q2 2018 per RZLT's latest filing, from $700000.0 in the prior quarter.
Over five years, Long-Term Debt Issuances peaked at $4.1 million in Q2 2018 and troughed at -$1.2 million in Q1 2014.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	-
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	-
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	-
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-
10	Rezolute	477.02 Mn	477.02 Mn	-	-

Historic Data

Download Data